1152405

Willis Holloway, Jr., M.D. — FEI 3006148455

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 9, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Oklahoma City, OK (United States)

Additional Details

Clinical Investigator (CI)